Is a complete ERNA research report available?

No complete published report is available for Ernexa Therapeutics Inc. (ERNA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Ernexa Therapeutics Inc. (ERNA)

NASDAQ: ERNA · USD

$2.00

+0.01 (+0.3%)· Recorded snapshot

Market cap	3.3M
Net income (ttm)	-12.3M
EPS (ttm)	-$18.6
Shares out	1.6M
Volume	3,269
Beta	2.65

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -12.3M
EPS (ttm): -$18.6
Market cap: 3.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0000748592
Company name	Ernexa Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	114082407
Earnings date	2026-11-10
Earnings time	amc
Employees	7
Employees change	1
Employees growth	16.67%
Enterprise value	$-1.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US1140824079
Last 10-K release date	2026-03-13
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2026-05-04
Last stock split type	Reverse
Market cap	$3.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$2.00
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ERNA
U.S. state	Massachusetts
Website	https://www.ernexatx.com

Metric

Value

Amount currency

USD

CIK code

0000748592

Company name

Ernexa Therapeutics Inc.

Country

United States

Country code

CUSIP number

114082407

Earnings date

2026-11-10

Earnings time

amc

Employees

Employees change

Employees growth

16.67%

Enterprise value

$-1.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US1140824079

Last 10-K release date

2026-03-13

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2026-05-04

Last stock split type

Reverse

Market cap

$3.3M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Price

$2.00

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ERNA

U.S. state

Massachusetts

Website

https://www.ernexatx.com

Metric	Value
Earnings yield	-930.16%
FCF / EV yield	622.82%
FCF yield	-272.87%
P/B ratio	0.73x
Price / tangible book value	1.02x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-930.16%

FCF / EV yield

622.82%

FCF yield

-272.87%

P/B ratio

0.73x

Price / tangible book value

1.02x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.8M
ROA	-105.57%
ROA (5Y)	-64.23%
ROCE	-346.97%
ROE	-320.72%
ROE (5Y)	-824.6%
ROIC	-170.89%

Metric

Value

Profit per employee

$-1.8M

ROA

-105.57%

ROA (5Y)

-64.23%

ROCE

-346.97%

ROE

-320.72%

ROE (5Y)

-824.6%

ROIC

-170.89%

Metric	Value
EPS growth quarters	2
EPS growth years	4
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-42,000
Depreciation and amortization	$47,000
EBIT	$-11.7M
EBITDA	$-11.7M
EPS	$-18.60
FCF per share	$-5.44
Financing cash flow	$9.6M
Free cash flow	$-8.9M
Free cash flow minus SBC	$-10.1M
Income taxes	$-96,000
Investing cash flow	$-42,000
Net cash flow	$713,000
Net income	$-12.3M
Operating cash flow minus SBC	$-10.1M
Operating income	$-11.7M
Stock-based compensation	$1.3M

Metric

Value

Capital expenditures

$-42,000

Depreciation and amortization

$47,000

EBIT

$-11.7M

EBITDA

$-11.7M

EPS

$-18.60

FCF per share

$-5.44

Financing cash flow

$9.6M

Free cash flow

$-8.9M

Free cash flow minus SBC

$-10.1M

Income taxes

$-96,000

Investing cash flow

$-42,000

Net cash flow

$713,000

Net income

$-12.3M

Operating cash flow minus SBC

$-10.1M

Operating income

$-11.7M

Stock-based compensation

$1.3M

Metric	Value
Book value per share	$2.73
Debt / equity	0.11
Interest coverage	-434.74
Long-term assets	$421,000
Long-term liabilities	$183,000
Net cash (debt)	$4.7M
Net cash / market cap	143.81%
Net cash growth	25.71%
Net debt / equity	-1.46
Piotroski F-Score	2
Property, plant and equipment	$396,000
Shareholders' equity	$3.2M
Tangible book value	$3.2M
Tangible book value per share	$2.73
Total assets	$6.3M
Total cash	$5M
Total debt	$349,000
Total liabilities	$3.1M
WACC	17.57%

Metric

Value

Book value per share

$2.73

Debt / equity

0.11

Interest coverage

-434.74

Long-term assets

$421,000

Long-term liabilities

$183,000

Net cash (debt)

$4.7M

Net cash / market cap

143.81%

Net cash growth

25.71%

Net debt / equity

-1.46

Piotroski F-Score

Property, plant and equipment

$396,000

Shareholders' equity

$3.2M

Tangible book value

$3.2M

Tangible book value per share

$2.73

Total assets

$6.3M

Total cash

$5M

Total debt

$349,000

Total liabilities

$3.1M

WACC

17.57%

Metric	Value
Current assets	$5.9M
Current liabilities	$2.9M
Current ratio	2.01
Net working capital	$-1.9M
Quick ratio	1.74
Working capital	$3M

Metric

Value

Current assets

$5.9M

Current liabilities

$2.9M

Current ratio

2.01

Net working capital

$-1.9M

Quick ratio

1.74

Working capital

$3M

Metric	Value
Buyback yield / dilution	-467.9%
Dividend yield	0%
Shareholder yield	-467.9%

Metric

Value

Buyback yield / dilution

-467.9%

Dividend yield

Shareholder yield

-467.9%

Metric	Value
150-day SMA	$5.31
1D price change	0.35%
1M price change	-41.94%
1M total return	-41.94%
1W price change	-5.21%
1W total return	-5.21%
1Y price change	-93.28%
1Y return CAGR	-93.29%
1Y total return	-93.28%
20-day SMA	$2.27
200-day SMA	$7.64
3M price change	-48.98%
3M total return	-48.98%
3Y price change	-99.61%
3Y return CAGR	-84.26%
3Y total return	-99.61%
50-day SMA	$3.40
50-day SMA vs 200-day SMA	50under200
52-week high	$71.50
52-week high date	2025-10-29
52-week low	$1.84
52-week low date	2026-10-19
5Y price change	-100%
5Y return CAGR	-87.43%
5Y total return	-100%
6M price change	-60%
6M total return	-60%
All-time high	$605,024.70
All-time high date	2021-05-03
All-time low	$1.84
All-time low date	2026-10-19
Average true range (ATR)	$0.26
Average volume	67.1K
Beta (1Y)	3.47
Beta (2Y)	1.96
Beta (5Y)	2.65
Change from 52-week high	-97.2%
Change from 52-week low	8.76%
Change from all-time high	-100%
Change from all-time low	8.75%
Change from open	4.71%
Day's gap	-4.16%
Dollar volume	$6,538
High price	$2.00
Low price	$1.91
Monthly RSI	47.51
Open price	$1.91
Position in 52-week range	100%
Premarket change	2.35%
Premarket close	$1.99
Premarket price	$2.04
Previous close	$1.99
Price vs 150-day SMA	-62.34%
Price vs 20-day SMA	-11.74%
Price vs 200-day SMA	-73.83%
Price vs 50-day SMA	-41.23%
Relative volume	0.05
RSI	30.4
Sharpe ratio	-1
Sharpe ratio (3Y)	-0.92
Sharpe ratio (5Y)	-1.3
Sortino ratio	-1.58
Sortino ratio (3Y)	-1.41
Sortino ratio (5Y)	-1.93
Volume	3.3K
Weekly RSI	30.69
YTD price change	-93.33%
YTD total return	-93.33%

Metric

Value

150-day SMA

$5.31

1D price change

0.35%

1M price change

-41.94%

1M total return

-41.94%

1W price change

-5.21%

1W total return

-5.21%

1Y price change

-93.28%

1Y return CAGR

-93.29%

1Y total return

-93.28%

20-day SMA

$2.27

200-day SMA

$7.64

3M price change

-48.98%

3M total return

-48.98%

3Y price change

-99.61%

3Y return CAGR

-84.26%

3Y total return

-99.61%

50-day SMA

$3.40

50-day SMA vs 200-day SMA

50under200

52-week high

$71.50

52-week high date

2025-10-29

52-week low

$1.84

52-week low date

2026-10-19

5Y price change

-100%

5Y return CAGR

-87.43%

5Y total return

-100%

6M price change

-60%

6M total return

-60%

All-time high

$605,024.70

All-time high date

2021-05-03

All-time low

$1.84

All-time low date

2026-10-19

Average true range (ATR)

$0.26

Average volume

67.1K

Beta (1Y)

3.47

Beta (2Y)

1.96

Beta (5Y)

2.65

Change from 52-week high

-97.2%

Change from 52-week low

8.76%

Change from all-time high

-100%

Change from all-time low

8.75%

Change from open

4.71%

Day's gap

-4.16%

Dollar volume

$6,538

High price

$2.00

Low price

$1.91

Monthly RSI

47.51

Open price

$1.91

Position in 52-week range

100%

Premarket change

2.35%

Premarket close

$1.99

Premarket price

$2.04

Previous close

$1.99

Price vs 150-day SMA

-62.34%

Price vs 20-day SMA

-11.74%

Price vs 200-day SMA

-73.83%

Price vs 50-day SMA

-41.23%

Relative volume

0.05

RSI

30.4

Sharpe ratio

-1

Sharpe ratio (3Y)

-0.92

Sharpe ratio (5Y)

-1.3

Sortino ratio

-1.58

Sortino ratio (3Y)

-1.41

Sortino ratio (5Y)

-1.93

Volume

3.3K

Weekly RSI

30.69

YTD price change

-93.33%

YTD total return

-93.33%

Metric	Value
Float	1.2M
Float percentage	74.6%
Shares change (QoQ)	49.37%
Shares change (YoY)	467.9%
Shares held by insiders	25.4%
Shares held by institutions	8.02%
Shares outstanding	1.6M
Short % of float	1.63%
Short % of shares	1.22%
Short ratio	0.4 days

Metric

Value

Float

1.2M

Float percentage

74.6%

Shares change (QoQ)

49.37%

Shares change (YoY)

467.9%

Shares held by insiders

25.4%

Shares held by institutions

8.02%

Shares outstanding

1.6M

Short % of float

1.63%

Short % of shares

1.22%

Short ratio

0.4 days

Ernexa Therapeutics Inc. (ERNA)

Price

Financial snapshot

Fair-value bridge

Latest news · ERNA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ERNA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ERNA

Frequently asked questions